HK100597A - Modified platelet factor-4 - Google Patents

Modified platelet factor-4

Info

Publication number
HK100597A
HK100597A HK100597A HK100597A HK100597A HK 100597 A HK100597 A HK 100597A HK 100597 A HK100597 A HK 100597A HK 100597 A HK100597 A HK 100597A HK 100597 A HK100597 A HK 100597A
Authority
HK
Hong Kong
Prior art keywords
mpf
leu
cpf
lys
ile
Prior art date
Application number
HK100597A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kant Gupta Shalley
Pal Singh Jai
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HK100597A publication Critical patent/HK100597A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK100597A 1992-09-25 1997-06-26 Modified platelet factor-4 HK100597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95279792A 1992-09-25 1992-09-25

Publications (1)

Publication Number Publication Date
HK100597A true HK100597A (en) 1997-08-08

Family

ID=25493243

Family Applications (1)

Application Number Title Priority Date Filing Date
HK100597A HK100597A (en) 1992-09-25 1997-06-26 Modified platelet factor-4

Country Status (24)

Country Link
US (3) US5538949A (cs)
EP (1) EP0589719B1 (cs)
JP (1) JPH06220091A (cs)
KR (1) KR940007059A (cs)
CN (1) CN1035257C (cs)
AT (1) ATE151777T1 (cs)
AU (1) AU665114B2 (cs)
BR (1) BR9303903A (cs)
CA (1) CA2106629A1 (cs)
CZ (1) CZ195193A3 (cs)
DE (1) DE69309827T2 (cs)
DK (1) DK0589719T3 (cs)
ES (1) ES2101237T3 (cs)
FI (1) FI934183A7 (cs)
GR (1) GR3023356T3 (cs)
HK (1) HK100597A (cs)
HU (1) HUT69928A (cs)
IL (1) IL107040A0 (cs)
MX (1) MX9305901A (cs)
MY (1) MY109158A (cs)
NO (1) NO933423L (cs)
NZ (1) NZ248724A (cs)
YU (1) YU61893A (cs)
ZA (1) ZA936925B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA936925B (en) * 1992-09-25 1995-03-20 Lilly Co Eli Modified platelet factor-4.
CA2148301A1 (en) * 1994-05-09 1995-11-10 Rama Belagaje Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第４因子の製造方法
CN100389126C (zh) * 1995-12-13 2008-05-21 儿童医学中心公司 内皮细胞增殖抑制剂及其应用方法
FR2774990B1 (fr) * 1998-02-16 2000-07-28 Inst Vaisseaux Et Du Sang Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant
CN1547477B (zh) 2001-09-12 2010-12-22 希格马托研究瑞士公司 具有抗血管生成活性且没有抗凝作用的作为类肝素酶抑制剂的部分脱硫酸化糖胺聚糖衍生物
US20090011981A1 (en) * 2004-09-15 2009-01-08 K.U. Leuven Research & Development Novel Inhibitors of Angiogenesis
CN114805536B (zh) * 2022-06-24 2022-09-02 北京百臻生物技术有限公司 一种人血小板因子4蛋白突变体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737580A (en) * 1985-03-15 1988-04-12 Oncogen Platelet related growth regulator
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5187075A (en) * 1989-01-26 1993-02-16 Sri International Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
EP0423641A3 (en) * 1989-10-18 1992-01-15 Nippon Mining Company Limited Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or tgfalpha
EP0541716A1 (en) * 1990-07-27 1993-05-19 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
ZA936925B (en) * 1992-09-25 1995-03-20 Lilly Co Eli Modified platelet factor-4.

Also Published As

Publication number Publication date
FI934183A0 (fi) 1993-09-24
GR3023356T3 (en) 1997-08-29
NZ248724A (en) 1995-10-26
CN1035257C (zh) 1997-06-25
CA2106629A1 (en) 1994-03-26
AU665114B2 (en) 1995-12-14
US5935928A (en) 1999-08-10
DK0589719T3 (da) 1997-09-08
AU4757393A (en) 1994-03-31
YU61893A (sh) 1996-02-19
BR9303903A (pt) 1994-06-14
DE69309827T2 (de) 1997-08-28
HU9302687D0 (en) 1993-12-28
KR940007059A (ko) 1994-04-26
US5512550A (en) 1996-04-30
CZ195193A3 (en) 1994-04-13
ES2101237T3 (es) 1997-07-01
FI934183L (fi) 1994-03-26
NO933423D0 (no) 1993-09-24
MX9305901A (es) 1994-05-31
CN1088216A (zh) 1994-06-22
IL107040A0 (en) 1993-12-28
JPH06220091A (ja) 1994-08-09
DE69309827D1 (de) 1997-05-22
ZA936925B (en) 1995-03-20
ATE151777T1 (de) 1997-05-15
HUT69928A (en) 1995-09-28
EP0589719A1 (en) 1994-03-30
MY109158A (en) 1996-12-31
NO933423L (no) 1994-03-28
EP0589719B1 (en) 1997-04-16
US5538949A (en) 1996-07-23
FI934183A7 (fi) 1994-03-26

Similar Documents

Publication Publication Date Title
Gubler et al. Recombinant human interleukin 1 alpha: purification and biological characterization.
US5401651A (en) DNA encoding ENA-78, a neutrophil activating factor
US7030223B2 (en) Megakaryocyte stimulating factors
US5504003A (en) Macrophage inflammatory protein-3 and -4
AU708903B2 (en) Human chemokine polypeptides
EP0616615B1 (en) Human interleukin-8 analogs
KR970002917B1 (ko) 인터루킨-i 억제제
EP0589719B1 (en) Modified platelet factor-4
US5877276A (en) Polypeptide agonists for human interleukin-8
EP0315289A2 (en) Cell growth inhibitory factor
US5627156A (en) Polypeptide agonists for human interleukin-8
US5876971A (en) Thrombin inhibitor from the saliva of protostomia
US5912232A (en) Anti-inflammatory polypeptide antagonists of human I1-8
WO1989010962A1 (en) Process for producing a human neutrophil chemotactic factor polypeptide
AU685079B2 (en) Peptide inhibitors of CXC intercrine molecules
EP0777494B1 (en) Human chemokine polypeptides
AU684539B2 (en) Macrophage inflammatory proteins-3, -4 and -1 Gamma
AU726538B2 (en) Pharmaceutical composition for increasing differentiation of osteoblasts
JPH07165796A (ja) トロンボモジュリン類発現用シグナルペプチド
AU5937299A (en) Human chemokine polypeptides
CA2198219A1 (en) Human chemokine polypeptides
AU5651800A (en) Human chemokine polypeptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)